IRF1 and COVID-19: In the acute hyperinflammatory phase, distinct subsets of monocyte-like cells (CD163+SLC39A8+CALR+ infMonos) and Tinf cells (MX1+IRF1+ISG15+) emerged, a phenomenon also observed in patients with sepsis and COVID-19.